Calcium

More than 99% of the body's calcium sits in bone as a structural mineral. The other 1%, circulating in blood and inside cells, runs an enormous amount of biology: nerve signalling, muscle contraction, blood clotting, hormone release, and gene transcription. That dual role is why calcium intake can't be optimised by simply maximising the number on the label. The skeleton wants enough; the bloodstream and the inside of every cell want it tightly regulated. Get the regulation wrong — usually by taking large isolated supplements — and the same mineral that builds bone starts calcifying arteries and pushing cells toward premature ageing.

The dietary-versus-supplement divide

This is the single most important thing to understand about calcium, and it is counter-intuitive: calcium from food protects the cardiovascular system, while calcium from supplements carries a probable risk signal — at the same total intake.

The protective side is consistent. In large prospective cohorts, higher dietary calcium intake tracks with lower all-cause mortality, lower cardiovascular disease, and fewer strokes, in a J-shaped curve where moderate-to-moderately-high intake is optimal and only extreme intakes reverse the benefit.^[1] The clearest illustration is the Multi-Ethnic Study of Atherosclerosis (MESA), which followed 5,448 adults free of cardiovascular disease for a decade: those with the highest total calcium intake had the lowest risk of developing new coronary artery calcification — the calcified plaque that hardens arteries.^[2]

The supplement side looks different. When the same MESA analysis isolated supplement use — adjusting for total intake — calcium supplements were independently associated with a 22% higher risk of developing coronary artery calcification.^[3] A widely cited meta-analysis of randomized trials found calcium supplements raised coronary heart disease risk by about 20% and myocardial infarction (heart attack) risk by about 21%.^[4] An earlier meta-analysis put the heart-attack signal at about 31%.^[5] And in a community cohort, supplement users who already had a high dietary calcium intake (above 1,400 mg/day) had more than double the all-cause mortality of others.^[6]

The evidence is genuinely contested, and honesty requires saying so. A 2020 umbrella review of randomized trials in almost 90,000 community-dwelling adults found no significant difference in mortality or major cardiovascular events between calcium supplementation and placebo.^[7] Mendelian-randomization (genetic) studies are split. Industry-aligned reviewers argue the harm trials had compliance and confounding problems. The fair reading is not "supplements are proven dangerous" but "supplements offer no cardiovascular upside and carry a plausible downside that food does not — so the burden of proof is on supplementing, not on eating calcium-rich food."

Why the form matters: the bolus effect

The mechanism that reconciles the divide is pharmacokinetic. Food delivers calcium slowly, bound up in protein, fat, and organic acids, so serum calcium barely moves. A supplement delivers 500–1,000 mg of elemental calcium at once, overwhelming the gut's regulated active-transport pathway and flooding the blood by passive diffusion. A single bolus keeps serum calcium elevated for up to eight hours.^[8]

That transient spike has two near-term effects measured in randomized trials of postmenopausal women: blood pressure rises by more than 5 mmHg versus placebo, and the blood becomes measurably more prone to clotting within four hours of the dose — calcium is a required cofactor at several steps of the clotting cascade.^[9] Repeated daily, these spikes are the plausible bridge between a calcium pill and the slow accumulation of arterial calcification. Food never produces the spike, which is why dietary calcium and supplemental calcium part ways in the outcome data.

The practical corollaries fall straight out of this: never take more than ~500 mg of elemental calcium at once, always take it with a meal, and prefer a slow-release form if you supplement at all.

How much, and where to get it

The recommended intake is 1,000 mg/day for adults 19–50 (and men to 70), rising to 1,200 mg/day for women over 50 and everyone over 70, as absorption efficiency falls with age from roughly 30% in young adults to 15–20% later in life.^[10] The tolerable upper limit is 2,000–2,500 mg/day — but it is nearly impossible to exceed from food alone; calcium toxicity is almost exclusively a supplement phenomenon.

Food sources are not equal, because plant inhibitors (oxalate, phytate) bind calcium in the gut:

The reader-level takeaway: dairy and low-oxalate greens are efficient; spinach is not, regardless of its high label content. A serial NHANES analysis (1999–2023) found mean dietary calcium has fallen (about 1,025 → 900 mg/day) while oxalate and phytate intake rose and population bone density dropped in parallel — so the food-first target is harder to hit than it used to be. See Bone density.

The synergistic triad: vitamin D, vitamin K2, and magnesium

Calcium should never be optimised in isolation. Whether absorbed calcium ends up in bone or in arterial walls is decided by three cofactors.

Vitamin D is the gatekeeper for absorption — it raises calcium uptake from a basal 10–15% to 30–40%, and is required to transcribe osteocalcin, the bone protein that locks calcium into the skeletal matrix. Target a 25-hydroxyvitamin D of 75–125 nmol/L (30–50 ng/mL). See Vitamin D.

Vitamin K2 directs the traffic. Vitamin D builds the calcium-binding proteins, but they are inert until vitamin K2 activates them (by carboxylation). Two matter: osteocalcin pulls calcium into bone, and Matrix Gla Protein sweeps calcium out of arterial walls. In a vitamin-K2-deficient state — common on modern diets — you absorb calcium efficiently but lack the machinery to route it, the setup behind the so-called "double burden" of simultaneous osteoporosis and arterial calcification.^[11] Practical dose: MK-7 at 90–180 µg/day, alongside D3. Coordinate with your prescriber if you take warfarin. See Vitamin K2.

Magnesium is calcium's biochemical counterweight. The two compete for the same gut transporters, so a heavy calcium load suppresses magnesium absorption and pushes the body toward relative magnesium depletion. The dietary calcium-to-magnesium ratio has become a useful risk marker: the optimum sits around 2.0–2.8, and ratios above ~3.0 — typically from heavy dairy or calcium supplements without enough magnesium-rich greens, nuts, and seeds — track with higher inflammation (interleukin-6) and worse cardiovascular and mortality outcomes.^[12][13] The corrective is to keep magnesium intake at roughly half of calcium intake. See Magnesium.

Calcium inside the cell: the longevity-specific angle

Beyond bone and arteries, the deepest connection to ageing happens inside cells. Resting cells keep cytosolic calcium extremely low and release it in brief, precise pulses to signal. Loss of that tight control is a recognised feature of cellular ageing.

As cells age, the pumps that clear calcium from the cytosol (the SERCA and plasma-membrane pumps) lose efficiency, and aged cells take 4–5 times longer to return calcium to baseline after a stimulus — a prolonged, toxic elevation. Senescent cells also leak calcium continuously from the endoplasmic reticulum; experimentally knocking down the leak channels lets cells escape senescence, which puts calcium leak close to a master switch in the ageing cascade.^[14] Oxidative stress amplifies the damage: it drives calcium transients that trigger the DNA-damage response and lock cells into senescence, while chelating intracellular calcium protects them and stimulates autophagy.^[15]

This connects to mitochondria. A modest, regulated flow of calcium into mitochondria (via the mitochondrial calcium uniporter, MCU) is needed to drive energy production — but overload opens the permeability transition pore and triggers cell death. The longevity protein SIRT1 helps gate this; as it declines with age, the gate is left open. Intriguingly, in nematode (C. elegans) lifespan models, slightly restricting calcium entry into mitochondria extends lifespan and preserves late-life mobility — a form of mitohormesis, where mild mitochondrial stress provokes a durable protective response.^[16][17]

These are mechanistic and largely preclinical findings, not a basis for any intervention. The honest reading: they explain why whole-body calcium overload is plausibly harmful at the cellular level, and they reinforce that the body's goal for calcium is precise regulation, not maximal quantity. The actionable levers that touch this biology are the ones already on the longevity list — exercise (which raises mitochondrial quality through the same hormetic pathway), not a calcium product.

Two clinical signals worth knowing

Dementia. A five-year study of women aged 70–92 found that those taking calcium supplements had roughly double the risk of incident dementia — and the risk was concentrated in women with prior cerebrovascular damage, where it rose several-fold in those with a history of stroke or white-matter lesions on brain imaging.^[18] The subtype most strongly linked was vascular dementia, consistent with the same coagulation-and-calcification mechanism that drives the cardiovascular signal. This is observational and specific to older women with existing vascular disease, but it's a reason for caution in exactly that group.

Parathyroid hormone (PTH) as a biomarker. When calcium and vitamin D status is chronically inadequate, the parathyroid glands raise PTH to pull calcium from bone — and chronically elevated PTH is an independent predictor of cardiovascular and all-cause mortality across large cohorts and meta-analyses.^[19] Among Chinese centenarians, the combination of low vitamin D, high PTH, and a high bone-resorption marker carried nearly triple the mortality risk.^[20] The lesson is not to chase PTH down with supplements, but that correcting genuine vitamin D and dietary calcium deficiency — which suppresses PTH into the normal range — is the validated win.

The kidney-stone paradox

For decades, calcium-stone formers were told to restrict dietary calcium. That was backwards. Adequate dietary calcium binds oxalate in the gut, forming an insoluble complex that leaves in the stool instead of being absorbed and concentrated in the urine — so higher dietary calcium is protective against the most common (calcium-oxalate) stones.^[21]

The critical variable is timing relative to food. Calcium taken with meals lowers urinary oxalate and stone-formation risk. The same calcium taken between meals or at bedtime — with no dietary oxalate to bind — is simply absorbed, raising urinary calcium while unbound oxalate from earlier meals is absorbed too, creating exactly the supersaturated urine that crystallises stones. This is the strongest single argument for the rule that any calcium supplement must be taken with food.

If you must supplement: choosing a form

Supplements should bridge a documented dietary gap, not act as the primary source. If you supplement, the form changes both absorption and side effects:

Calcium citrate is the sensible default for general use — acid-independent, well-tolerated, and the right choice for older adults or anyone on a proton-pump inhibitor.^[22] Microcrystalline hydroxyapatite is the form most aligned with the bolus-effect logic, since its slow, sustained serum profile avoids the spike while still suppressing bone turnover.^[23][24] The headline bioavailability claims for calcium lysinate come from a single industry trial and shouldn't be over-weighted.^[25]

A practical calcium protocol

1. Target 1,000–1,200 mg/day, food first. Dairy and low-oxalate greens (kale, broccoli, bok choy), calcium-set tofu, and bone-in fish. Don't count spinach.
2. Supplement only the gap. Estimate dietary intake; supplement the shortfall, not a flat 1,000 mg on top.
3. Never bolus. Cap any single dose at ~500 mg of elemental calcium and split larger needs across the day.
4. Always with a meal. It blunts the serum spike and binds dietary oxalate, neutralising the kidney-stone risk.
5. Take the triad. Vitamin D3 to a 25(OH)D of 75–125 nmol/L (30–50 ng/mL), vitamin K2 (MK-7) 90–180 µg/day, and enough magnesium to keep the dietary Ca:Mg ratio near 2–2.8.
6. Prefer citrate, or hydroxyapatite if you want the slowest serum profile.
7. For bone, calcium is necessary but not sufficient — the dominant osteogenic stimulus is heavy resistance training. See Bone density.
8. Be especially cautious with supplements if you're an older woman with existing vascular disease — that's where both the dementia and cardiovascular signals concentrate. Work with a clinician.

What's overrated

• "More calcium means stronger bones." Above the requirement, extra calcium doesn't add bone — and as a supplement it adds cardiovascular and stone risk. The dose-response flattens; the harm doesn't.
• High-dose calcium monotherapy. A large pill of calcium alone, without vitamin D, K2, and magnesium, is the single configuration the evidence most clearly cautions against.
• Restricting dietary calcium to prevent stones. Backwards — adequate dietary calcium taken with meals is protective.
• Spinach as a calcium source. Oxalate binds almost all of it.
• Coral, oyster-shell, and "whole-food" calcium marketing. No demonstrated advantage over plain citrate, and shell-derived products carry occasional heavy-metal concerns.

For the broader picture of which supplements help, which are gap-fillers, and which cause harm, see Supplements and Supplements to avoid.

Further reading

• Anderson JJB et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification: 10-Year Follow-up of MESA. J Am Heart Assoc 2016.^[26]
• Myung S-K et al. Calcium supplements and risk of cardiovascular disease — systematic review and meta-analysis. J Am Coll Nutr 2019.^[27]
• Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction — meta-analysis. BMJ 2010.^[28]
• Michaëlsson K et al. Long-term calcium intake and rates of all-cause and cardiovascular mortality. BMJ 2013.^[29]
• Burckhardt P. Acute effects of calcium supplements on blood pressure and coagulation. 2015.^[30]
• van Ballegooijen AJ et al. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health. 2017.^[31]
• Rosanoff A et al. Physical activity, dietary calcium-to-magnesium ratio and mortality. 2020.^[32]
• Kern J et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology 2016.^[33]
• Late-life survival and mobility via mitohormesis by reducing mitochondrial calcium. 2025.^[34]
• Calcium and vitamin D supplementation and kidney stone disease — narrative review. 2021.^[35]
• NIH Office of Dietary Supplements. Calcium — Health Professional Fact Sheet.^[36]

---